Charming Medical Faces Nasdaq Trading Suspension Nov. 9 Unless It Appeals

PUBT · 1d ago
Charming Medical Faces Nasdaq Trading Suspension Nov. 9 Unless It Appeals
  • Charming Medical received Nasdaq's October 29, 2026, delisting determination for its Nasdaq-listed securities (MCTA).
  • Trading will be suspended at the November 9, 2026, open unless an appeal is requested by November 5, 2026.
  • The SEC suspended trading on November 11, 2025, over potential third-party manipulation; Nasdaq subsequently halted trading.
  • Nasdaq has not communicated any finding of company wrongdoing.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Charming Medical Ltd. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001213900-26-116108), on November 05, 2026, and is solely responsible for the information contained therein.